1 |
Shechter T, Shorer Z, Kramer U, Lerman-Sagie T, Ronen E, Rotem R, et al. Adverse reactions of topiramate and lamotrigine in children. Pharmacoepidemiol Drug Saf 2005;14:187-92
DOI
ScienceOn
|
2 |
Ben-Zeev B, Watemberg N, Augarten A, Brand N, Yahav Y, Efrati O. Oligohidrosis and hyperthermia: pilot study of a novel topiramate adverse effect. J Child Neurol 2003;18:254-7
DOI
|
3 |
Cho NJ, Lee YJ, Lew Y, Kim DK, Lee SH. Evaluation of treatment effect of primary hyperhidrosis using skin surface hydrometer. Korean J Dermatol 1994;32:369-75
|
4 |
Ritter F, Glauser TA, Elterman RD, Wyllie E. Effectiveness, tolerability and safety of topiramate in children with partial-onset seizures. Epilepsia 2000;41:82-5
DOI
|
5 |
Wilner A, Raymong K, Pollard R. Topiramate and metabolic acidosis. Epilepsia 1999;40:792-5
DOI
|
6 |
Dogson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000;41:35-9
DOI
ScienceOn
|
7 |
Shank RP. Gardocki JF, Streeter AJ. An overview of the pre-clinical aspects of topiramate: pharmacology, pharmacokinetics and mechanisms of action. Epilepsia 2000;41:3-9
DOI
|
8 |
Arcas J, Ferre T, Roche MC, Martinez A, Lopez V. Hypohidrosis related to the administration of topiramate to children. Epilepsia 2001;42:1363-5
DOI
|
9 |
Shimizu T, Yamashita Y, Satoi M, Togo A, Wada N, Matsuishi T, et al. Heat stroke-like episode in child caused by zonisamide. Brain Dev 1997;19:366-9
DOI
ScienceOn
|
10 |
Okamura A, Hayakawa F, Kuno K, Watanabe K. Oligohid-rosis caused by zonisamide. No To Hattatsu(Tokyo) 1996;28:44-7
|
11 |
Nieto-Barrera M, Nieto-Jimenez M, Candau R, Ruiz del Portal L. Anhidrosis and hyperthermia associated with treatment with topiramate. Rev Neurol 2002;34:114-6
|
12 |
Laskey AL, Korn DE, Moorjani BI, Patel NC, Tobias JD. Central hyperventilation related to administration of topiramate. Pediatr Neurol 2000;22:305-8
DOI
ScienceOn
|
13 |
Carolis P, Magnifico F, Pierangeli G, Rinaldi R, Galeotti M, Cevoli S, et al. Transient hypohidrosis induced by topiramate. Epilepsia 2003;44:974-6
DOI
ScienceOn
|
14 |
Chadwick DW, Marson T, Kadir Z. Clinical administration of new antiepileptic drugs: an overview of safety and efficacy. Epilepsia 1996;37:17-22
DOI
ScienceOn
|
15 |
Philippi H, Bor R, Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia 2002;43:744-7
DOI
ScienceOn
|
16 |
Bjoro K, Gjerstad L, Bentdal O, Osnes S, Schrumpf E. Topiramate and fulminant liver failure. Lancet 1998;352:119-122
|
17 |
Brigmann JV, Tashian RE, Spicer SS. Immunohistochemical localization of carbonic anhydrase II and I in ecrine sweat glands from control subjects and patients with cystic fibrosis. Am J Pathol 1983;112:250-5
|
18 |
Franz H, Philp HP, Harion BS. Studies on sweating. A new quantitative method of assaying sweat-delivery to circumscribed areas of the skin surface. J Invest Dermatol 1951;17:241-9
DOI
ScienceOn
|
19 |
Ferrer T, Ramos MJ, Perez-Sales P, Perez-Jimenez A, Alvarez E. Sympathetic sudomotor function and aging. Muscle Nerve 1995;18:395-401
DOI
ScienceOn
|
20 |
Levisohn PM. Safety and tolerability of topiramate in children. J Child Neurol 2000;15:S22-6
DOI
|
21 |
Tagami H, Kanamaru Y, Inoue K. Watersorption-desorption test of the skin in vivo for functional assessment of the stratum corneum. J Invest Dermatol 1982;78:425-8
DOI
ScienceOn
|
22 |
David RH. Evaluation sweat gland activity with imprint techniques. J Invest Dermatol 1972;58:78-84
DOI
ScienceOn
|
23 |
Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders, I: normal sweat gland function. J Am Acad Dermatol 1989;20:537-63
DOI
ScienceOn
|
24 |
Mikaeloff Y, Saint-Martin A, Mancini J. Topiramate:efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res 2003;53:225-32
DOI
ScienceOn
|
25 |
SarKany I, Gaylarde P. A new method for demonstration of sweat gland activity. Br J Dermatol 1968;80:601-5
DOI
ScienceOn
|
26 |
Sohn TS, Son HS, Yu JM, Cha BS, Min KW, Baik SH. Evaluation of the indicator testin the diagnosis of peripheral neuropathy among type 2 diabetic patients. J Kor Diabetes Assoc 2005;29:247-53
|
27 |
Yilmaz K, Tatli B, Yaramis A, Aydinli N, Caliskan M, Ozmen M. Symptomatic and asymptomatic hypohidrosis in children under topiramate treatment. Turk J Pediatr 2005;47:359-63
|
28 |
Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Opthalmol 2001;119:1210-1
|
29 |
Takeoka M, Holmes GL, Thiele E, Bourgeois BF, Helmers SL, Duffy FH. Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia 2001;42:387-92
DOI
|
30 |
Mathias CJ, Bannister R. Investigation of autonomic disorders. In: Bannister R, Mathias CJ, eds. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 3rd ed. Oxford: Oxford University Press 1992:225-90
|
31 |
Randall WC, Kimura KK. The pharmacology of sweating. Pharmacol Rev 1955;7:365-97
|